Insider filing · NBIX
Stephen A Sherwin
Director
profile →
Neurocrine Biosciences, Inc.
NBIX · Healthcare · 59 filings in 24 months
ticker →
Stephen A Sherwin sold $4.1M of Neurocrine Biosciences (NBIX)
Executed Jun 5, disclosed Jun 9, 4 days later.
Value, as filed
$4.1M
25,000 sh across 5 lots
Executed
Jun 5
the trade date, as filed
Disclosed
Jun 9
4 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
SSStephen A Sherwin (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Neurocrine Biosciences, Inc. (NBIX). The largest single filing was $4.1M of NBIX (25,000 sh across 5 lots, as filed), executed Jun 5.
The name
NBIXHealthcare · Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunolog…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Stephen A Sherwin in NBIX
NBIXSALE
Neurocrine Biosciences, Inc.
$1.6M13,831 sh × $116.69
Exec Feb 13 2025
Filed Feb 14 2025 · 5:30 PM ET